Cargando…
Antibody responses after a single dose of ChAdOx1 nCoV-19 vaccine in healthcare workers previously infected with SARS-CoV-2
BACKGROUND: Recent reports demonstrate robust serological responses to a single dose of messenger RNA (mRNA) vaccines in individuals previously infected with SARS-CoV-2. Data on immune responses following a single-dose adenovirus-vectored vaccine expressing the SARS-CoV-2 spike protein (ChAdOx1 nCoV...
Autores principales: | Havervall, Sebastian, Marking, Ulrika, Greilert-Norin, Nina, Ng, Henry, Gordon, Max, Salomonsson, Ann-Christin, Hellström, Cecilia, Pin, Elisa, Blom, Kim, Mangsbo, Sara, Phillipson, Mia, Klingström, Jonas, Hober, Sophia, Nilsson, Peter, Åberg, Mikael, Thålin, Charlotte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8357428/ https://www.ncbi.nlm.nih.gov/pubmed/34391088 http://dx.doi.org/10.1016/j.ebiom.2021.103523 |
Ejemplares similares
-
Duration of SARS-CoV-2 Immune Responses Up to Six Months Following Homologous or Heterologous Primary Immunization with ChAdOx1 nCoV-19 and BNT162b2 mRNA Vaccines
por: Marking, Ulrika, et al.
Publicado: (2022) -
Impact of SARS‐CoV‐2 infection on vaccine‐induced immune responses over time
por: Havervall, Sebastian, et al.
Publicado: (2022) -
Immune responses after omicron infection in triple-vaccinated health-care workers with and without previous SARS-CoV-2 infection
por: Blom, Kim, et al.
Publicado: (2022) -
Mucosal immune responses following a fourth SARS-CoV-2 vaccine dose
por: Bladh, Oscar, et al.
Publicado: (2023) -
Point prevalence of SARS-CoV-2 infection among healthcare workers in March and June 2023 in Sweden
por: Blom, Kim, et al.
Publicado: (2023)